During the past decade, Na Homolce Hospital conducted 85 clinical trials. In the 10-year time frame, 85 clinical trials started and 29 clinical trials were completed, i.e. on average, 34.1% percent of trials that started reached the finish line to date. In the past 5 years, 36 clinical trials started and 19 clinical trials were completed. i.e. 52.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Na Homolce Hospital" #1 sponsor was "Abbott Medical Devices" with 9 trials, followed by "Biosense Webster, Inc." with 8 trials sponsored, "Boston Scientific Corporation" with 7 trials sponsored, "Farapulse, Inc." with 7 trials sponsored and "Medtronic Cardiac Rhythm and Heart Failure" with 7 trials sponsored. Other sponsors include 95 different institutions and companies that sponsored additional 69 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Na Homolce Hospital" #1 collaborator was "Biosense Webster, Inc." with 2 trials as a collaborator, "MLM Medical Labs GmbH" with 2 trials as a collaborator, "Massachusetts General Hospital" with 2 trials as a collaborator, "University Hospital Hradec Kralove" with 2 trials as a collaborator and "nabios GmbH" with 2 trials as a collaborator. Other collaborators include 18 different institutions and companies that were collaborators in the rest 28 trials.

According to Clinical.Site data, the most researched conditions in "Na Homolce Hospital" are "Atrial Fibrillation" (27 trials), "Paroxysmal Atrial Fibrillation" (14 trials), "Heart Failure" (9 trials), "Ventricular Tachycardia" (9 trials) and "Bradycardia" (6 trials). Many other conditions were trialed in "Na Homolce Hospital" in a lesser frequency.

Most popular intervention types in "Na Homolce Hospital" are "Device" (106 trials), "Drug" (21 trials), "Procedure" (12 trials), "Other" (6 trials) and "Diagnostic Test" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Ablation" (3 trials), "VytronUS Ablation System" (3 trials), "Boston Scientific Vessix Renal Denervation System" (2 trials) and "Gemcitabine" (2 trials). Other intervention names were less common.

The vast majority of trials in "Na Homolce Hospital" are 135 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Na Homolce Hospital". 1 are not yet recruiting, 18 are recruiting, 26 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 69 completed trials in Na Homolce Hospital, 1 suspended trials, and 13 terminated clinical trials to date.

Out of the total trials that were conducted in Na Homolce Hospital, 5 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 8 trials, and there were also 94 trials that are defined as “Not Applicable".